-
Chief Financial Officer Of Pulmonx Makes $224.56 Thousand Sale
Wednesday, September 22, 2021 - 12:49pm | 401Read More...Derrick Sung, Chief Financial Officer at Pulmonx (NASDAQ:LUNG), made a large insider sell on September 21, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Sung sold 6,000 shares of Pulmonx at prices ranging from $...
-
UPDATE: Bernstein Research Downgrades St. Jude Medical on Limited Near-Term Catalysts
Tuesday, November 5, 2013 - 10:23am | 187Read More...In a report published Tuesday, Bernstein Research analyst Derrick Sung downgraded the rating on St. Jude Medical (NYSE: STJ) from Outperform to Market Perform, and lowered the price target from $64.00 to $62.00. In the report, Bernstein Research noted, “We are downgrading St. Jude Medical to...
